These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12193060)

  • 41. Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae.
    Paris D; Townsend KP; Humphrey J; Obregon DF; Yokota K; Mullan M
    Atherosclerosis; 2002 Apr; 161(2):293-9. PubMed ID: 11888511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mevalonate availability affects human and rat resistance vessel function.
    Roullet JB; Xue H; Roullet CM; Fletcher WS; Cipolla MJ; Harker CT; McCarron DA
    J Clin Invest; 1995 Jul; 96(1):239-44. PubMed ID: 7615793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Lovastatin on Brain Cancer Cells.
    Amadasu E; Kang R; Usmani A; Borlongan CV
    Cell Transplant; 2022; 31():9636897221102903. PubMed ID: 35670207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linkage of the isoprenoid biosynthetic pathway with induction of DNA synthesis in mouse lymphocytes. Effects of compactin on mitogen-induced lymphocytes in serum-free medium.
    Perkins SL; Ledin SF; Stubbs JD
    Biochim Biophys Acta; 1982 Apr; 711(1):83-9. PubMed ID: 6279167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD43 polarization in unprimed T cells can be dissociated from raft coalescence by inhibition of HMG CoA reductase.
    Gubina E; Chen T; Zhang L; Lizzio EF; Kozlowski S
    Blood; 2002 Apr; 99(7):2518-25. PubMed ID: 11895788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New findings on the action of HMG-CoA-reductase inhibitors].
    Laufs U; Böhm M; Liao JK
    Dtsch Med Wochenschr; 1997 Oct; 122(41):1255-9. PubMed ID: 9378055
    [No Abstract]   [Full Text] [Related]  

  • 47. Fibrates and C-reactive protein.
    Kostoula A; Elisaf M
    Clin Chim Acta; 2003 Feb; 328(1-2):197. PubMed ID: 12559619
    [No Abstract]   [Full Text] [Related]  

  • 48. Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine carrier gene expression.
    Iacobazzi V; Convertini P; Infantino V; Scarcia P; Todisco S; Palmieri F
    Biochem Biophys Res Commun; 2009 Oct; 388(4):643-7. PubMed ID: 19665003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of fibrates on lipid metabolism and the blood coagulation system].
    Paragh G; Balogh Z
    Orv Hetil; 2000 Jan; 141(1):23-6. PubMed ID: 10673854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Luteolin inhibits endothelin-1 secretion in cultured endothelial cells.
    Kozakai T; Yamanaka A; Ichiba T; Toyokawa T; Kamada Y; Tamamura T; Ichimura T; Maruyama S
    Biosci Biotechnol Biochem; 2005 Aug; 69(8):1613-5. PubMed ID: 16116295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statin islands and PPAR ligands in platelets.
    Phipps RP; Blumberg N
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):620-1. PubMed ID: 19369654
    [No Abstract]   [Full Text] [Related]  

  • 52. Elevation of alkaline phosphatase by retinol in bovine endothelial cells and its possible relationship to lipid biosynthesis.
    Adams SE; Bishop EJ; Melnykovych G
    Biochim Biophys Acta; 1986 Feb; 885(2):146-53. PubMed ID: 2868757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HMG CoA reductase inhibitors and PPAR-alpha activators: are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials?
    Fruchart JC; Duriez P
    Curr Atheroscler Rep; 2002 Nov; 4(6):403-4. PubMed ID: 12361484
    [No Abstract]   [Full Text] [Related]  

  • 54. Antihyperlipidaemic agents. Drug interactions of clinical significance.
    Farmer JA; Gotto AM
    Drug Saf; 1994 Nov; 11(5):301-9. PubMed ID: 7873090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PPAR agonists as direct modulators of the vessel wall in cardiovascular disease.
    Buchan KW; Hassall DG
    Med Res Rev; 2000 Sep; 20(5):350-66. PubMed ID: 10934348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of clofibric acid on the turnover of the fatty acid-binding protein identified in cultured endothelial cells from bovine aorta.
    Robers M; Loddenkötter B; Kresse H; Spener F
    Lipids; 1993 Jun; 28(6):483-6. PubMed ID: 8355575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia.
    Abbas A; Milles J; Ramachandran S
    Clin Med Insights Endocrinol Diabetes; 2012; 5():13-30. PubMed ID: 22879796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The future of endothelin-receptor antagonism as treatment for systemic hypertension.
    Vorobiof G; Blaxall BC; Bisognano JD
    Curr Hypertens Rep; 2006 Apr; 8(1):35-44. PubMed ID: 16600158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.
    van Oostrom AJ; van Wijk J; Cabezas MC
    Drugs; 2004; 64 Suppl 2():19-41. PubMed ID: 15765889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.
    Kandoussi A; Martin F; Hazzan M; Noël C; Fruchart JC; Staels B; Duriez P
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():81S-83S. PubMed ID: 12193060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.